Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis

PHASE4CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Actinic Keratosis
Interventions
DRUG

ingenol mebutate gel 0.015%

-Face or Scalp arm (Referred to Face/Scalp arm): Apply ingenol mebutate gel 0.015% once daily for 3 consecutive days

DRUG

ingenol mebutate gel 0.05%

-Trunk or Extremities arm (Referred to Trunk/Extremities arm): Apply ingenol mebutate gel 0.05% once daily for 2 consecutive days

Trial Locations (1)

15355

Korea University Ansan Hospital, Ansan-si

Sponsors
All Listed Sponsors
collaborator

LEO Pharma

INDUSTRY

collaborator

Chonnam National University Hospital

OTHER

collaborator

Severance Hospital

OTHER

collaborator

Ajou University School of Medicine

OTHER

collaborator

Asan Medical Center

OTHER

collaborator

Samsung Medical Center

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

Dong-A University Hospital

OTHER

collaborator

Korea University Anam Hospital

OTHER

collaborator

Seoul National University Hospital

OTHER

lead

Korea University

OTHER

NCT02716714 - Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis | Biotech Hunter | Biotech Hunter